With an initial investment of over 17 million euros for the development of 5,600 square meters of new laboratories dedicated to pharmaceutical technology and analytical chemistry, Alfasigma confirms its commitment to Research and Development. L’inauguration of ‘Labio 4.0 Marino Golinelli’, this morning in the Pomezia pharmaceutical group plant, is part of a broader corporate strategy of progressive investment in R&D, which allows Alfasigma, one of the top five pharmaceutical companies with Italian capital, to stand out both nationally and internationally for innovation and technological development.
Read Also
- Church asks the government for greater responsibility before returning to classes Aug 15, 2021
- The Borg have arrived: but from the mud not from the stars Jul 20, 2021
- “I was very scared”: Sherlyn was able to flee Cancun due to the arrival of Hurricane Delta Oct 7, 2020
- Putin spoke about his reaction to the amendment of a student in a conversation about the Northern War Sep 3, 2021
- Domenicali: “Respect for Pirelli, they have a difficult task” | FormulaPassion.it Jul 11, 2021
- Carla Bruni au natural : they post a message of hope to a few days of the déconfinement May 6, 2020
- Puerto Rico remains attentive to the development of monkeypox May 22, 2022